Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...

The Procter & Gamble Company's stagnating revenue growth and premium valuation suggest it's time to explore better value ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights into the rapidly evolving use of glucagon-like peptide-1 receptor agonists ...